Benzinga's Top Pre-Market NASDAQ Gainers (CYTX, GLUU, MYGN, HILL)

Cytori Therapeutics Inc CYTX rose 11.94% to $6 in the pre-market session. CYTX received an approval from The Netherlands for initiating pivotal stem & regenerative cell heart attack trial in Europe. Glu Mobile Inc GLUU added 5.74% to $2.21 in the pre-market session. GLUU priced its new stock offering at $2.05 per share. Myriad Genetics Inc MYGN moved up 4.80% to $21.83 in the pre-market session. MYGN is all set to report its FQ2 results on January 27. Dot Hill Systems Corporation HILL soared 3.46% to $2.99 in the pre-market trading. HILL lifted its Q4 projections. Read more from Benzinga's Markets.